Current approaches for the disease often rely on subcutaneous administrations of GLP-1 agonists, a method that can be inconvenient for people. Scientists are diligently developing groundbreaking administration methods to improve individual adherence and results. These feature oral formulations, inhaled delivery, and even long-acting devices, offeri

New Evidence Shows 22.8% Weight Loss in Long-term Study The SURMOUNT-4 trial has shown remarkable results for eco-friendly weight management. Our analysis of this landmark study reveals that participants lost an impressive 25.3% of their weight with tirzepatide, whereas the placebo group achieved only 9.9%. Maintaining weight loss has always bee